Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Original oral ganciclovir schedules are not oral valganciclovir schedules. The source grouping of HD and PD is preserved and flagged for modality-specific revalidation.
Check source scope before reading a dose
Cytovene-IV - labeled renal guidance
Product / population
Ganciclovir (Cytovene-IV), adult IV induction or maintenance for labeled CMV indications
All record notes are retained here, including notes about sources not selected in this review.
Cytovene-IV - product and source limitations
Infuse over one hour. Check CrCl and blood counts. The label's nondialysis table separates induction from maintenance; dosing below CrCl 10 without HD is not supplied by the HD row.
What to reconcile: Verify the current prescribing information for this presentation.
Renal guidance: 2, adult renal dosage table and hemodialysis
Limits that apply to these rows
Infuse over one hour. Check CrCl and blood counts. The label's nondialysis table separates induction from maintenance; dosing below CrCl 10 without HD is not supplied by the HD row.
Adult renal dosing in this source
Adult CrCl (mL/min)
Induction, IV over 1 hour
Maintenance, IV over 1 hour
50-69
2.5 mg/kg every 12 hours
2.5 mg/kg every 24 hours
25-49
2.5 mg/kg every 24 hours
1.25 mg/kg every 24 hours
10-24
1.25 mg/kg every 24 hours
0.625 mg/kg every 24 hours
<10, on HD
1.25 mg/kg after HD, 3 times weekly
0.625 mg/kg after HD, 3 times weekly
Read the retained text before reformatting
For adult intermittent hemodialysis (HD), induction must not exceed 1.25 mg/kg IV after HD three times weekly. Maintenance must not exceed 0.625 mg/kg IV after HD three times weekly. At CrCl 50-69, induction is 2.5 mg/kg every 12 hours and maintenance 2.5 mg/kg daily; at 25-49, use 2.5 and 1.25 mg/kg daily, respectively; at 10-24, use 1.25 and 0.625 mg/kg daily. Infuse over one hour. Check CrCl and blood counts. The label's nondialysis table separates induction from maintenance; dosing below CrCl 10 without HD is not supplied by the HD row.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.